AU Stock MarketDetailed Quotes
PAR Paradigm Biopharmaceuticals Ltd
- 0.425
- -0.020-4.49%
20min DelayTrading Dec 12 11:11 AET
148.51MMarket Cap-2.13P/E (Static)
0.430High0.415Low1.52MVolume0.430Open0.445Pre Close646.74KTurnover0.61052wk High0.50%Turnover Ratio349.43MShares0.16552wk Low-0.2EPS TTM129.65MFloat Cap4.500Historical HighLossP/E (Static)305.06MShs Float0.165Historical Low-0.2EPS LYR3.37%Amplitude--Dividend TTM6.25P/B1Lot Size--Div YieldTTM
Paradigm Biopharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||||||
| Cash income from operating activities | -0.24%7.41M | -22.68%7.43M | 185.03%9.61M | -6.93%3.37M | 56.18%3.62M | 30.74%2.32M | 1.77M | -500 | |
| Revenue from customers | 259.76%82.9K | -71.71%23.04K | --81.44K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other cash income from operating activities | -1.05%7.33M | -22.26%7.4M | 182.62%9.53M | -6.93%3.37M | 56.18%3.62M | 30.74%2.32M | --1.77M | ---- | ---500 |
| Cash paid | -38.54%-74.19M | -28.01%-53.55M | -8.59%-41.83M | -160.33%-38.52M | -68.67%-14.8M | -11.91%-8.77M | -74.28%-7.84M | -21.93%-4.5M | -3.69M |
| Payments to suppliers for goods and services | -38.54%-74.19M | -28.01%-53.55M | -8.59%-41.83M | -160.33%-38.52M | -68.67%-14.8M | -11.91%-8.77M | -34.27%-7.84M | -58.27%-5.84M | ---3.69M |
| Other cash payments from operating activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.34M | ---- |
| Direct interest paid | 12.46%-14.37K | 42.67%-16.42K | 24.09%-28.63K | -10.40%-37.72K | ---34.17K | ---- | ---- | ---- | ---- |
| Direct interest received | -11.00%845.9K | 1,882.92%950.46K | -81.56%47.93K | -76.79%259.96K | 1,154.96%1.12M | 70.60%89.26K | 88.56%52.32K | -72.65%27.75K | --101.44K |
| Operating cash flow | -45.94%-65.94M | -40.31%-45.19M | 7.80%-32.21M | -246.18%-34.93M | -58.52%-10.09M | -5.85%-6.37M | -34.52%-6.01M | -24.59%-4.47M | ---3.59M |
| Investing cash flow | |||||||||
| Cash flow from continuing investing activities | -88.11%668.37K | 186.21%5.62M | -42,405.08%-6.52M | 99.20%-15.34K | -151.11%-1.92M | -765.55K | |||
| Net PPE purchase and sale | ---- | ---- | ---- | 75.86%-30.78K | -617.27%-127.54K | -482.41%-17.78K | 84.70%-3.05K | -53.87%-19.95K | ---12.97K |
| Net intangibles purchas and sale | ---- | ---- | ---- | 74.65%-850 | 20.13%-3.35K | 65.84%-4.2K | 99.35%-12.29K | -152.79%-1.9M | ---752.58K |
| Net investment purchase and sale | ---- | ---- | ---- | -87.83%700K | 188.52%5.75M | ---6.5M | ---- | ---- | ---- |
| Cash from discontinued investing activities | |||||||||
| Investing cash flow | ---- | ---- | ---- | -88.11%668.37K | 186.21%5.62M | -42,405.08%-6.52M | 99.20%-15.34K | -151.11%-1.92M | ---765.55K |
| Financing cash flow | |||||||||
| Cash flow from continuing financing activities | -54.94%28.18M | 89,087.38%62.53M | -93.01%70.12K | -97.22%1M | -56.45%36.05M | 1,306.92%82.78M | -1.70%5.88M | -17.18%5.99M | 7.23M |
| Net issuance payments of debt | ---- | 102.81%416.34K | 98.01%205.29K | -94.53%103.68K | --1.9M | ---- | ---- | ---- | ---- |
| Net common stock issuance | -54.55%28.28M | --62.22M | ---- | -97.02%1.02M | -58.62%34.25M | 1,306.92%82.78M | -1.70%5.88M | -18.77%5.99M | --7.37M |
| Net other financing activities | 2.06%-102.34K | 22.70%-104.49K | -10.93%-135.17K | -30.22%-121.85K | ---93.57K | ---- | ---- | ---- | ---141.39K |
| Cash from discontinued financing activities | |||||||||
| Financing cash flow | -54.94%28.18M | 89,087.38%62.53M | -93.01%70.12K | -97.22%1M | -56.45%36.05M | 1,306.92%82.78M | -1.70%5.88M | -17.18%5.99M | --7.23M |
| Net cash flow | |||||||||
| Beginning cash position | 41.99%56.33M | -44.15%39.67M | -31.65%71.03M | 43.67%103.92M | 2,857.77%72.34M | -5.60%2.45M | -13.59%2.59M | 2,301.43%3M | --124.86K |
| Current changes in cash | -317.70%-37.77M | 153.99%17.35M | 3.38%-32.14M | -205.30%-33.26M | -54.81%31.59M | 48,239.95%69.89M | 64.38%-145.18K | -114.18%-407.54K | --2.87M |
| Effect of exchange rate changes | -7.96%-744.54K | -189.04%-689.67K | 108.61%774.58K | --371.3K | ---- | ---- | ---- | ---- | ---- |
| End cash Position | -68.37%17.82M | 41.99%56.33M | -44.15%39.67M | -31.65%71.03M | 43.67%103.92M | 2,857.77%72.34M | -5.60%2.45M | -13.59%2.59M | --3M |
| Free cash from | -45.94%-65.94M | -40.31%-45.19M | 7.88%-32.21M | -242.05%-34.96M | -60.03%-10.22M | -5.94%-6.39M | 5.69%-6.03M | -46.84%-6.39M | ---4.35M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Heat List
AU
Overall
Symbol
Price
% Chg
No Data